Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-09-09

AUTHORS

S. Zhao, E. Liu, K. Wei, Y. Wang, Y. Li, B. Huang, Y. Chen, P. Yang

ABSTRACT

Higher sustained virological response (SVR) rates after treating with peginterferon than after treating with interferon have been obtained in some randomized clinical trials (RCTs) in Chinese patients with chronic hepatitis C (CHC). However, the numbers of patients included in these clinical trials were too small to draw a clear conclusion. Therefore, a new meta-analysis including a large number of patients was needed to compare peginterferon with interferon in the treatment of Chinese CHC patients. A search of Medline, the China National Knowledge Infrastructure, the Wanfang Database, and the China Biomedical Database for relevant articles published between 1966 and 2009 was performed. RCTs comparing the use of peginterferon and interferon for the treatment of Chinese patients with CHC were assessed. Of the 236 studies screened, 18 RCTs including 1,148 patients (659 treated with peginterferon therapy and 489 treated with interferon therapy) were analyzed. The total SVR rates obtained in patients treated with peginterferon were significantly higher than those obtained in patients treated with interferon (64% vs. 40%; relative risk, 1.56; 95% confidence interval: 1.28–1.91; p < 0.01), but the difference between the peginterferon α-2b and interferon α-2b treatments was not significant. Withdrawal rates were similar between patients treated with peginterferon and interferon. Chinese patients with CHC have a greater likelihood of achieving an SVR with peginterferon α-2a. More... »

PAGES

51-57

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10096-010-1051-7

DOI

http://dx.doi.org/10.1007/s10096-010-1051-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048534807

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20827497


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "China", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepacivirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon alpha-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyethylene Glycols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viremia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Withholding Treatment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
            "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhao", 
        "givenName": "S.", 
        "id": "sg:person.01217761561.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
            "Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "E.", 
        "id": "sg:person.016446245112.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wei", 
        "givenName": "K.", 
        "id": "sg:person.0702161631.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702161631.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Y.", 
        "id": "sg:person.0604025321.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Y.", 
        "id": "sg:person.01101266316.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "B.", 
        "id": "sg:person.0652140521.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652140521.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Y.", 
        "id": "sg:person.0720253721.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China", 
          "id": "http://www.grid.ac/institutes/grid.43169.39", 
          "name": [
            "Research Institute of Atherosclerotic Disease, Xi\u2019an Jiaotong University School of Medicine, Shaanxi, China", 
            "Laboratory Animal Center, Xi\u2019an Jiaotong University School of Medicine, 710061, Shaanxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-09-09", 
    "datePublishedReg": "2010-09-09", 
    "description": "Higher sustained virological response (SVR) rates after treating with peginterferon than after treating with interferon have been obtained in some randomized clinical trials (RCTs) in Chinese patients with chronic hepatitis C (CHC). However, the numbers of patients included in these clinical trials were too small to draw a clear conclusion. Therefore, a new meta-analysis including a large number of patients was needed to compare peginterferon with interferon in the treatment of Chinese CHC patients. A search of Medline, the China National Knowledge Infrastructure, the Wanfang Database, and the China Biomedical Database for relevant articles published between 1966 and 2009 was performed. RCTs comparing the use of peginterferon and interferon for the treatment of Chinese patients with CHC were assessed. Of the 236 studies screened, 18 RCTs including 1,148 patients (659 treated with peginterferon therapy and 489 treated with interferon therapy) were analyzed. The total SVR rates obtained in patients treated with peginterferon were significantly higher than those obtained in patients treated with interferon (64% vs. 40%; relative risk, 1.56; 95% confidence interval: 1.28\u20131.91; p\u2009<\u20090.01), but the difference between the peginterferon \u03b1-2b and interferon \u03b1-2b treatments was not significant. Withdrawal rates were similar between patients treated with peginterferon and interferon. Chinese patients with CHC have a greater likelihood of achieving an SVR with peginterferon \u03b1-2a.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10096-010-1051-7", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4967813", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093599", 
        "issn": [
          "0934-9723", 
          "1435-4373"
        ], 
        "name": "European Journal of Clinical Microbiology & Infectious Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "keywords": [
      "chronic hepatitis C", 
      "randomized clinical trials", 
      "Chinese patients", 
      "hepatitis C", 
      "clinical trials", 
      "high sustained virological response rates", 
      "sustained virological response rates", 
      "virological response rates", 
      "Chinese CHC patients", 
      "use of peginterferon", 
      "total SVR rate", 
      "peginterferon \u03b1-2a", 
      "China National Knowledge Infrastructure", 
      "China Biomedical Database", 
      "peginterferon \u03b1-2b", 
      "number of patients", 
      "search of MEDLINE", 
      "National Knowledge Infrastructure", 
      "CHC patients", 
      "SVR rates", 
      "\u03b1-2a", 
      "peginterferon", 
      "Wanfang Database", 
      "\u03b1-2b", 
      "interferon \u03b1", 
      "patients", 
      "response rate", 
      "interferon", 
      "Knowledge Infrastructure", 
      "relevant articles", 
      "greater likelihood", 
      "biomedical databases", 
      "treatment", 
      "trials", 
      "withdrawal rate", 
      "clear conclusions", 
      "MEDLINE", 
      "rate", 
      "database", 
      "conclusion", 
      "SVR", 
      "differences", 
      "likelihood", 
      "study", 
      "number", 
      "large number", 
      "search", 
      "use", 
      "article", 
      "infrastructure"
    ], 
    "name": "Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C", 
    "pagination": "51-57", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048534807"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10096-010-1051-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20827497"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10096-010-1051-7", 
      "https://app.dimensions.ai/details/publication/pub.1048534807"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_504.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10096-010-1051-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10096-010-1051-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10096-010-1051-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10096-010-1051-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10096-010-1051-7'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      20 PREDICATES      94 URIs      86 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10096-010-1051-7 schema:about N16e58b5083f54b32bec335ea2be12c6b
2 N18192ee5c4b747118e4179db47aeeecf
3 N1e8d0b37c6734ec5a9c2b17ff814243c
4 N39e492e682004070ad99f4fc902223b8
5 N40e435d11d724dcdb3bb398b9904f514
6 N4f85f88c611c429b95cbe7bcbf3c5c86
7 N5709fd8b8f6949c992896d4b5c8ee424
8 N5a9d8a6a51204619b8e30bb8656c6718
9 N5e14f4b7a84c432e867f95766354d2d4
10 N5f7eb27ad4fc48f68b68b4c1bef89688
11 N6a3d29d240c34bdf8e987259927e7395
12 N70509bf083a447ce9e5dd80c3c63fd83
13 N75f2c2ebf17c49d0b46470f6d466ba0a
14 N87b5610908914fc78306d59df8411727
15 N8f4159d189404322b1ea060b2045acdd
16 Na27c5bffbe9f49b58548c18b6d93ca32
17 Nb8be6f4399124331b9a7d256d6686b57
18 Nc6b22bef9211443e948a557fbea61637
19 Nda32c921567d48fcb947fe78a283bdc2
20 Ne37778cb408c419e81da0c8c0636a7f8
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N657062cf666e412bb54667e45816e82c
24 schema:datePublished 2010-09-09
25 schema:datePublishedReg 2010-09-09
26 schema:description Higher sustained virological response (SVR) rates after treating with peginterferon than after treating with interferon have been obtained in some randomized clinical trials (RCTs) in Chinese patients with chronic hepatitis C (CHC). However, the numbers of patients included in these clinical trials were too small to draw a clear conclusion. Therefore, a new meta-analysis including a large number of patients was needed to compare peginterferon with interferon in the treatment of Chinese CHC patients. A search of Medline, the China National Knowledge Infrastructure, the Wanfang Database, and the China Biomedical Database for relevant articles published between 1966 and 2009 was performed. RCTs comparing the use of peginterferon and interferon for the treatment of Chinese patients with CHC were assessed. Of the 236 studies screened, 18 RCTs including 1,148 patients (659 treated with peginterferon therapy and 489 treated with interferon therapy) were analyzed. The total SVR rates obtained in patients treated with peginterferon were significantly higher than those obtained in patients treated with interferon (64% vs. 40%; relative risk, 1.56; 95% confidence interval: 1.28–1.91; p < 0.01), but the difference between the peginterferon α-2b and interferon α-2b treatments was not significant. Withdrawal rates were similar between patients treated with peginterferon and interferon. Chinese patients with CHC have a greater likelihood of achieving an SVR with peginterferon α-2a.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf N5a6fca98cc654d3ca4cb4a87ca3996fc
30 Ndcd63df0d3c14999b2e6eb7ce687afde
31 sg:journal.1093599
32 schema:keywords CHC patients
33 China Biomedical Database
34 China National Knowledge Infrastructure
35 Chinese CHC patients
36 Chinese patients
37 Knowledge Infrastructure
38 MEDLINE
39 National Knowledge Infrastructure
40 SVR
41 SVR rates
42 Wanfang Database
43 article
44 biomedical databases
45 chronic hepatitis C
46 clear conclusions
47 clinical trials
48 conclusion
49 database
50 differences
51 greater likelihood
52 hepatitis C
53 high sustained virological response rates
54 infrastructure
55 interferon
56 interferon α
57 large number
58 likelihood
59 number
60 number of patients
61 patients
62 peginterferon
63 peginterferon α-2a
64 peginterferon α-2b
65 randomized clinical trials
66 rate
67 relevant articles
68 response rate
69 search
70 search of MEDLINE
71 study
72 sustained virological response rates
73 total SVR rate
74 treatment
75 trials
76 use
77 use of peginterferon
78 virological response rates
79 withdrawal rate
80 α-2a
81 α-2b
82 schema:name Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C
83 schema:pagination 51-57
84 schema:productId N5428f2e7d2994ef18b8bb7ad7933ace7
85 N6eac4a83e4304dc5aaac866552c007e6
86 Nae75bf7b19734820ae552ef5e78b6ce8
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048534807
88 https://doi.org/10.1007/s10096-010-1051-7
89 schema:sdDatePublished 2022-10-01T06:35
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N0256dfb761a34218990a7c409ed175d2
92 schema:url https://doi.org/10.1007/s10096-010-1051-7
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N0256dfb761a34218990a7c409ed175d2 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N0dc61ea1ce634782869f8e2cd1ac6281 rdf:first Nf32618375e864d35b05db123abc037b1
99 rdf:rest rdf:nil
100 N16e58b5083f54b32bec335ea2be12c6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Polyethylene Glycols
102 rdf:type schema:DefinedTerm
103 N18192ee5c4b747118e4179db47aeeecf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Adolescent
105 rdf:type schema:DefinedTerm
106 N1e8d0b37c6734ec5a9c2b17ff814243c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Adult
108 rdf:type schema:DefinedTerm
109 N33e18160c13d4bb1929c324aa33b7091 rdf:first sg:person.01101266316.28
110 rdf:rest Na7be4430225a4589b2826e70962035d6
111 N39e492e682004070ad99f4fc902223b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Interferon-alpha
113 rdf:type schema:DefinedTerm
114 N40e435d11d724dcdb3bb398b9904f514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Hepatitis C, Chronic
116 rdf:type schema:DefinedTerm
117 N4509d60c9ca64944a020154eebb4c473 rdf:first sg:person.0720253721.55
118 rdf:rest N0dc61ea1ce634782869f8e2cd1ac6281
119 N4f85f88c611c429b95cbe7bcbf3c5c86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Withholding Treatment
121 rdf:type schema:DefinedTerm
122 N5428f2e7d2994ef18b8bb7ad7933ace7 schema:name doi
123 schema:value 10.1007/s10096-010-1051-7
124 rdf:type schema:PropertyValue
125 N5709fd8b8f6949c992896d4b5c8ee424 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Aged
127 rdf:type schema:DefinedTerm
128 N5a6fca98cc654d3ca4cb4a87ca3996fc schema:volumeNumber 30
129 rdf:type schema:PublicationVolume
130 N5a9d8a6a51204619b8e30bb8656c6718 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 N5e14f4b7a84c432e867f95766354d2d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 N5f7eb27ad4fc48f68b68b4c1bef89688 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name China
138 rdf:type schema:DefinedTerm
139 N657062cf666e412bb54667e45816e82c rdf:first sg:person.01217761561.81
140 rdf:rest N7145cc98bde14919a9191a5dbeabf261
141 N6a3d29d240c34bdf8e987259927e7395 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Recombinant Proteins
143 rdf:type schema:DefinedTerm
144 N6eac4a83e4304dc5aaac866552c007e6 schema:name pubmed_id
145 schema:value 20827497
146 rdf:type schema:PropertyValue
147 N70509bf083a447ce9e5dd80c3c63fd83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antiviral Agents
149 rdf:type schema:DefinedTerm
150 N7145cc98bde14919a9191a5dbeabf261 rdf:first sg:person.016446245112.43
151 rdf:rest Nb45eff14f058487893fa7100c82a0c1b
152 N75f2c2ebf17c49d0b46470f6d466ba0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Viremia
154 rdf:type schema:DefinedTerm
155 N87b5610908914fc78306d59df8411727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Young Adult
157 rdf:type schema:DefinedTerm
158 N8f4159d189404322b1ea060b2045acdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Female
160 rdf:type schema:DefinedTerm
161 Na27c5bffbe9f49b58548c18b6d93ca32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Treatment Outcome
163 rdf:type schema:DefinedTerm
164 Na7be4430225a4589b2826e70962035d6 rdf:first sg:person.0652140521.33
165 rdf:rest N4509d60c9ca64944a020154eebb4c473
166 Nae75bf7b19734820ae552ef5e78b6ce8 schema:name dimensions_id
167 schema:value pub.1048534807
168 rdf:type schema:PropertyValue
169 Nb45eff14f058487893fa7100c82a0c1b rdf:first sg:person.0702161631.42
170 rdf:rest Nbf549a93da1a43fa9afc3cec185a7204
171 Nb8be6f4399124331b9a7d256d6686b57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Hepacivirus
173 rdf:type schema:DefinedTerm
174 Nbf549a93da1a43fa9afc3cec185a7204 rdf:first sg:person.0604025321.87
175 rdf:rest N33e18160c13d4bb1929c324aa33b7091
176 Nc6b22bef9211443e948a557fbea61637 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Interferon alpha-2
178 rdf:type schema:DefinedTerm
179 Nda32c921567d48fcb947fe78a283bdc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Middle Aged
181 rdf:type schema:DefinedTerm
182 Ndcd63df0d3c14999b2e6eb7ce687afde schema:issueNumber 1
183 rdf:type schema:PublicationIssue
184 Ne37778cb408c419e81da0c8c0636a7f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Randomized Controlled Trials as Topic
186 rdf:type schema:DefinedTerm
187 Nf32618375e864d35b05db123abc037b1 schema:affiliation grid-institutes:grid.43169.39
188 schema:familyName Yang
189 schema:givenName P.
190 rdf:type schema:Person
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
195 schema:name Clinical Sciences
196 rdf:type schema:DefinedTerm
197 sg:grant.4967813 http://pending.schema.org/fundedItem sg:pub.10.1007/s10096-010-1051-7
198 rdf:type schema:MonetaryGrant
199 sg:journal.1093599 schema:issn 0934-9723
200 1435-4373
201 schema:name European Journal of Clinical Microbiology & Infectious Diseases
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01101266316.28 schema:affiliation grid-institutes:grid.43169.39
205 schema:familyName Li
206 schema:givenName Y.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101266316.28
208 rdf:type schema:Person
209 sg:person.01217761561.81 schema:affiliation grid-institutes:grid.43169.39
210 schema:familyName Zhao
211 schema:givenName S.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217761561.81
213 rdf:type schema:Person
214 sg:person.016446245112.43 schema:affiliation grid-institutes:grid.43169.39
215 schema:familyName Liu
216 schema:givenName E.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016446245112.43
218 rdf:type schema:Person
219 sg:person.0604025321.87 schema:affiliation grid-institutes:grid.43169.39
220 schema:familyName Wang
221 schema:givenName Y.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604025321.87
223 rdf:type schema:Person
224 sg:person.0652140521.33 schema:affiliation grid-institutes:grid.43169.39
225 schema:familyName Huang
226 schema:givenName B.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652140521.33
228 rdf:type schema:Person
229 sg:person.0702161631.42 schema:affiliation grid-institutes:grid.43169.39
230 schema:familyName Wei
231 schema:givenName K.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702161631.42
233 rdf:type schema:Person
234 sg:person.0720253721.55 schema:affiliation grid-institutes:grid.43169.39
235 schema:familyName Chen
236 schema:givenName Y.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720253721.55
238 rdf:type schema:Person
239 grid-institutes:grid.43169.39 schema:alternateName Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi’an Jiaotong University School of Medicine, Shaanxi, China
240 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
241 Research Institute of Atherosclerotic Disease, Xi’an Jiaotong University School of Medicine, Shaanxi, China
242 schema:name Key Laboratory of Environment and Genes Related to Diseases of the Education Ministry, Xi’an Jiaotong University School of Medicine, Shaanxi, China
243 Laboratory Animal Center, Xi’an Jiaotong University School of Medicine, 710061, Shaanxi, China
244 Research Institute of Atherosclerotic Disease, Xi’an Jiaotong University School of Medicine, Shaanxi, China
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...